SNSS Financial Facts
Total revenues: 610KResearch and development: 6.61M
See Full Income Statement
Total current assets: 33.95M
Accrued clinical expense: 2.01M
See Full Balance Sheet
Sunesis Pharmaceuticals Inc. (SNSS) Earnings
|
Expand Research on SNSS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -39.1% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/14  |
 |
Q413 | -$0.15 | -$0.20 | +$0.05 | $2M | $1.37M | N/A |  | | Details |
| 8/5/14 |
|
Q214 | -$0.20 | -$0.17 | -$0.03 | $2M | $1.32M | N/A | | | Details |
| 7/29/13 |
Q213 | -$0.18 | -$0.21 | +$0.03 | $1.99M | $1.22M | N/A | | | Details | |
| 3/13/13 |
Q412 | -$0.20 | -$0.19 | -$0.01 | $1.99M | $320K | N/A | | | Details | |
| 11/5/15 |
|
Q315 | -$0.09 | -$0.15 | +$0.06 | $700K | $1.09M | N/A | | | Details |
| 5/5/16 |
|
Q116 | -$0.12 | -$0.12 | $0.00 | $600K | $1K | N/A | | | Details |
| 11/2/17 |
|
Q317 | N/A | -$0.37 | N/A | N/A | $220K | = | N/A | N/A | |
| 5/8/18 | |
Q118 | -$0.21 | -$0.27 | +$0.06 | $200K | $200K | = | | | Details |
